Additionally, phalloidin staining illustrated that VPA treatment inhibited F-actin contraction and marginal clustering in HCC cells, with this effect being obstructed by the p300/CBP inhibitor, thereby underscoring the critical role of histone acetylation in the pharmacological action of VPA (Figure S7E). The gene discussed is EP300; the disease is hepatocellular carcinoma.